Sequent Scientific Limited reported a strong operational performance for the quarter ended March 31, 2025 (Q4 FY25), marking a turnaround from a loss-making position in the same period last year.
The company posted a consolidated net profit of ₹9.32 crore in Q4 FY25, a sharp improvement from a net loss of ₹0.9 crore in Q4 FY24. On a sequential basis, profit also grew substantially from ₹3.44 crore in Q3 FY25.
Revenue from operations for the March quarter stood at ₹401.7 crore, rising 11.2% year-on-year from ₹361.2 crore in Q4 FY24 and up 2.9% from ₹390.8 crore in the December 2024 quarter. Total income came in at ₹403.3 crore for Q4 FY25.
Total expenses were ₹386.8 crore, compared to ₹378.5 crore in Q4 FY24 and ₹388.2 crore in Q3.
Profit before tax stood at ₹16.63 crore, compared to ₹7.35 crore in Q4 FY24.
Tax expenses were ₹5.93 crore, leading to a profit after tax of ₹10.38 crore, versus ₹1.27 crore in Q4 FY24.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
